High CV risk in young people is a 'delayed' crisis

Published Date: 08 Mar 2023

Cardiovascular disease is "unacceptably" high and increasing among American adults ages 20 to 44, requiring aggressive prevention.

Read Full News

Latest News

TADV Saves Limbs in No-Option CLTI Patients

More than 80% of no-option chronic limb-threatening ischemia patients avoided amputation for 6 months after the procedure while enjoying improved wound healing and reduced pain.

Underground Hospitals: Is Combat Medicine Entering a New Era?

Ukrainian clinicians increasingly rely on protected underground facilities as drone threats complicate evacuation and strain traditional battlefield treatment models.

France Focuses on Drugs That Raise Fall Risk in Older Adults

Long-term benzodiazepines and anticholinergics drive falls in seniors; prioritize nonpharmacologic care and deprescribing to cut injuries and hospitalizations.

Uraemic Marker Predicts Mortality After Kidney Transplant

Plasma levels of symmetric dimethylarginine are independently associated with an increased risk for mortality in adult kidney transplant recipients, a prospective study finds.

GLP-1 Drugs Tied to Cardiovascular Benefits in T1D

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant increase in diabetic ketoacidosis compared with those who do not.

Transient Neurologic Symptoms: What Clinicians Miss

Speakers warn that transient neurologic events may conceal high-risk vascular disease, seizures, or amnestic syndromes requiring rapid evaluation.

Todays Updates

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

Todays Updates

Hidradenitis Suppurativa Tied to Higher Cardiovascular Risks

Individuals with HS show higher risks for cardiovascular outcomes, including hypertension, coronary or ischemic heart disease, venous thromboembolism, and myocardial infarction, in a meta-analysis.

Latest News

More than 80% of no-option chronic limb-threatening ischemia patients avoided amputation for 6 months after the procedure while enjoying improved wound healing and reduced pain.

Ukrainian clinicians increasingly rely on protected underground facilities as drone threats complicate evacuation and strain traditional battlefield treatment models.

Long-term benzodiazepines and anticholinergics drive falls in seniors; prioritize nonpharmacologic care and deprescribing to cut injuries and hospitalizations.

Plasma levels of symmetric dimethylarginine are independently associated with an increased risk for mortality in adult kidney transplant recipients, a prospective study finds.

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant increase in diabetic ketoacidosis compared with those who do not.

Speakers warn that transient neurologic events may conceal high-risk vascular disease, seizures, or amnestic syndromes requiring rapid evaluation.

News All Time

Preventive Care With the Most Bang for Your Buck

An analysis of USPSTF and ACIP recommendations shows wide variation in impact, helping clinicians prioritize care during time-constrained visits.

Long Delays in Cardiac Amyloidosis Diagnosis Persist

Most older adults with transthyretin cardiac amyloidosis face a several-month delay in diagnosis after a heart failure diagnosis, despite overall increased diagnostic frequency of amyloidosis.

Early Physical Activity Safe After MI

Patients who started physical activity within a week of discharge for a heart attack have no greater cardiovascular risk than less active patients in a recent study.

Clopidogrel Beats Aspirin Long-Term After PCI

When dual antiplatelet therapy was stopped 12 months after PCI, clopidogrel monotherapy lowered cardiovascular and bleeding events relative to aspirin.

Jehovah’s Witnesses Allow Autologous Blood in Brazil

Jehovah’s Witnesses now allow members to choose to use their own blood in some procedures, reigniting debate over bloodless surgery, patient autonomy, and broader blood-conservation care.

BP After Stroke Thrombectomy: Individualization Needed?

Results of a new trial suggest that BP targets after thrombectomy in patients with acute ischemic stroke may need to be individualized depending on several different patient characteristics.

New STEMI Score Predicts Mortality After Angioplasty

A new seven factor score predicts long term mortality after ST-elevation myocardial infarction in patients who undergo angioplasty, and it performs similarly to or better than existing models.

Too Few Children With Overweight/Obesity Assessed for OSA

Children were more likely to undergo an evaluation if they had public insurance, had a higher BMI, had English as a primary language, or were a toddler or preschool aged.

Syncing Sleep, Fasting Improves Blood Sugar Markers

Patients interested in time-restricted eating should make sense it works their own sleep cycle.

Lipoprotein(a) Levels Matter Even in Primary Prevention

Elevated lipoprotein(a) levels are associated with increased non-calcified plaque volume and higher odds of high-risk features at the plaque level in adults without prior coronary artery disease.

Severe Chest Pain in Newly Diagnosed Colorectal Cancer

Case study illustrates iatrogenic risks not to be underestimated

Personalizing Treatment in Narcolepsy and Idiopathic Hypersomnia: Integrating the Latest Evidence Into Optimized Management Plans

Personalizing Treatment in Narcolepsy and Idiopathic Hypersomnia: Integrating the Latest Evidence Into Optimized Management Plans

From Detection to Decision: Anticoagulation Strategies in Subclinical Atrial Fibrillation

From Detection to Decision: Anticoagulation Strategies in Subclinical Atrial Fibrillation

Changing the Trajectory of Cardiorenal Disease: Optimizing CKD Treatment to Improve Patient Outcomes

Changing the Trajectory of Cardiorenal Disease: Optimizing CKD Treatment to Improve Patient Outcomes

Anticoagulation in the Balance: Navigating DOAC Use in NVAF and Liver Disease

Anticoagulation in the Balance: Navigating DOAC Use in NVAF and Liver Disease

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Assess, Align, Act: A Practical Guide to ASCVD Risk Assessment and LDL-C Goal Setting

Recommended News For You

Immunotherapy Remains Little Used in Head and Neck Cancer

Universal screening approach achieves a comparable detection rate of lung cancer

Fear of hair loss might cause some to reject cancer treatment

Breast cancer prevention: How nurse practitioners and physician assistants can help

Major Shifts in Urothelial Cancer Care: Immunotherapy Redefines Standards

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

CAR T-Cell Therapy for Kidney Cancer Builds on Efficacy Record

Recommended Articles For You

Obesity as a major risk factor for cancer 

Uncovering New Hope for Follicular Lymphoma Patients 

MASLD and Cancer Risk: Pathogenic Links and Clinical Implications Reviewed 

Anemia in Older Adults: Causes, Clinical Impact, and Evidence-Based Management 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Dasatinib Fails to Improve Outcomes in CBF-AML

2.

Millions of men could benefit from faster scan to diagnose prostate cancer

3.

WHO Warns Loosely Regulated Nicotine Pouches Risk Youth Addiction

4.

Adopted cancer cells and the effects of their presence.

5.

Gene therapy and chemotherapy may be combined in novel ways to treat bone cancer.

1.

Unveiling the Hidden Benefits of Lymphedema Treatment

2.

HSC Failure in Fanconi Anemia: Mechanisms, Models, and Emerging Therapeutic Pathways

3.

IGF2BP1 in Blood Disorders: Therapeutic Potential and Comprehensive Functional Insights

4.

Nuclear Medicine's Role in Battling Women's Cancers

5.

Lactic Acid-Linked lncRNAs in Wilms Tumor: Decoding the Tumor Microenvironment & Prognosis

1.

International Lung Cancer Congress®

2.

Genito-Urinary Oncology Summit 2026

3.

Future NRG Oncology Meeting

4.

ISMB 2026 (Intelligent Systems for Molecular Biology)

5.

Annual International Congress on the Future of Breast Cancer East

1.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part II

2.

Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV

3.

Efficient Management of First line ALK-rearranged NSCLC - Part II

4.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part V

5.

The Reign of the CROWN Trial and the Dawn of a New Era in Frontline Management- Further Discussion

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot